AQXP Insider Trading Activity and SEC Form 4 Filings
AQXP insider trading summary
No open-market insider purchases or sales of Aquinox Pharmaceuticals, Inc (AQXP) have been reported on SEC Form 4 in the past 12 months.
Latest AQXP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 7, 2019 | 667, L.P. | Director | Buy | $17K (5,869 @ $2.96) |
| Aug 7, 2019 | Baker Brothers Life Sciences LP | Director | Buy | $57K (18,943 @ $3.02) |
| Aug 7, 2019 | Felix Baker | Director | Buy | $2K (531 @ $2.96) |
| Aug 7, 2019 | Baker Bros. Advisors LP | Director | Buy | $17K (5,869 @ $2.96) |
| Aug 7, 2019 | Julian Baker | Director | Buy | $17K (5,869 @ $2.96) |
| Aug 7, 2019 | Baker Bros. Advisors LP | Director | Buy | $57K (18,943 @ $3.02) |
| Aug 7, 2019 | Baker Bros. Advisors (GP) LLC | Director | Buy | $2K (531 @ $2.96) |
| Aug 7, 2019 | Baker Brothers Life Sciences LP | Director | Buy | $2K (531 @ $2.96) |
| Aug 7, 2019 | Julian Baker | Director | Buy | $2K (531 @ $2.96) |
| Aug 7, 2019 | Felix Baker | Director | Buy | $57K (18,943 @ $3.02) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.